OUR BRANDS

Treatments for Common Skin Conditions

Treatments designed to help manage common skin conditions. You can access the Important Safety Information and Prescribing Information for each product by visiting the product websites linked below.

You are encouraged to report all side effects or Adverse Drug Events (ADEs) of prescription drugs to the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088. You are also encouraged to report side effects or ADEs to our Drug Safety Department at 1-855-531-1859 with as much information as available. You may report Accutane® side effects or ADEs by calling the Accutane Medical Information line at 1-844-325-3350.

Save on Your Prescription

Eligible patients may qualify for reduced out-of-pocket costs through the Journey Total Access Program.

INDICATION

EMROSI is a prescription medicine used to treat adults with pimples and bumps (inflammatory lesions) caused by a condition called rosacea.

EMROSI should not be used for the treatment of infections. It is not known if EMROSI is safe and effective in children.

IMPORTANT SAFETY INFORMATION

  • Do not take EMROSI if you are allergic to any tetracycline medicines.
  • Before using EMROSI, tell your healthcare provider about all the other medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. EMROSI and other medicines may affect each other and cause serious side effects.
  • Do not use EMROSI if you are pregnant, may become pregnant or are nursing. If you become pregnant while using EMROSI, talk to your doctor. Tetracycline medicine when taken by mouth during pregnancy, infancy and/or childhood up to the age of 8 years may permanently discolor teeth (yellow-gray-brown) and may slow the growth of bones.
  • Protect your skin from the sun while using EMROSI. Avoid sunlight or artificial sunlight such as sunlamps or tanning beds. Stop using EMROSI if you get a sunburn.
  • When taken by mouth, minocycline may cause feelings of lightheadedness, dizziness or a spinning feeling. You should not drive or operate dangerous machinery if you have these symptoms.

EMROSI is an extended-release capsule that contains minocycline, a tetracycline medicine. Tetracyclines, when taken by mouth, may cause serious side effects, including: serious skin or allergic reactions which can cause skin redness, rash, hives, sores in your mouth, or your skin blisters and peels; swelling of your face, eyes, lips, tongue, or throat; trouble swallowing or breathing; blood in your urine; fever, yellowing of the skin or the whites of your eyes (jaundice), dark colored urine; pain on the right side of the stomach area (abdominal pain); chest pain or abnormal heartbeats; swelling in your legs, ankles, and feet; diarrhea which may be caused by an infection that can cause watery or bloody stools; loss of appetite; tiredness; unexplained bleeding or bleeding more easily than normal; confusion; sleepiness; vision changes, including blurred vision, double vision, or permanent vision loss; unusual headaches; fever; rash; joint pain; body weakness. Call your doctor right away if these side effects occur.

The most common side effects of EMROSI include stomach upset or burning (dyspepsia) after eating or drinking. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Journey Medical Corporation at 1-855-531-1859.

Please see full Prescribing Information, including Patient Product Information.

 

What is QBREXZA?

QBREXZA (glycopyrronium) cloth, 2.4%, is a prescription medication used on the skin to treat excessive underarm sweating (primary axillary hyperhidrosis) in people 9 years of age and older.

IMPORTANT SAFETY INFORMATION

QBREXZA is for use on the skin in the underarm only. Wash your hands right away after you apply QBREXZA and have thrown away the cloth in the trash out of the reach of children and others. What is the most important information I should know about QBREXZA? Who should not use QBREXZA? Do not use QBREXZA if you have certain medical conditions that can be made worse by taking an anticholinergic medicine such as glaucoma, severe ulcerative colitis (UC) or certain other serious bowel problems associated with UC, myasthenia gravis, and Sjogren’s syndrome. What should I tell my healthcare provider before using QBREXZA?
  • Tell your healthcare provider about all your medical conditions, including if you have prostate, bladder or kidney problems or problems passing urine; if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if QBREXZA will harm your unborn baby or pass into breastmilk.
  • Tell your healthcare provider and pharmacist about all the medicines you take, including prescription and over-the-counter medicines and especially any anticholinergic medicines.
What are the possible side effects of QBREXZA? Serious side effects may include:
  • New or worsened urinary retention: People who use QBREXZA may develop new or worse urinary retention. Urinary retention can result from a blockage in your bladder or a larger than normal prostate. Stop using QBREXZA and call your healthcare provider right away if you experience any of the following symptoms: difficulty urinating; urinating frequently; urinating in a weak stream or drips; full bladder or difficulty emptying your bladder.
  • Problems with control of your body temperature: QBREXZA can cause you to have decreased sweating in areas other than the underarm leading to overheating and the development of heat illness when in hot or very warm temperatures. Stop using QBREXZA and call your healthcare provider right away if you experience any of the following symptoms: lack of sweating on your body; hot or red skin; decreased alertness or passing out; fast, weak pulse; fast, shallow breathing; increased body temperature.
  • Blurred Vision: Avoid touching eyes. Stop using QBREXZA and call your healthcare provider if you develop blurred vision. Do not drive, operate machinery, or do hazardous work until your vision is clear.
The most common side effects of QBREXZA in clinical studies were dry mouth; dilation of the pupils; sore throat; skin redness, burning/stinging or itching in underarm area; headache; problems with urination; blurred vision; nasal, throat, eye, and skin dryness; and constipation. These are not all the possible side effects of QBREXZA. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including Patient Product Information.
 

IMPORTANT SAFETY INFORMATION

INDICATIONS AND USAGE:

For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.

SUMMARY OF RISK INFORMATION FOR EURAX CREAM

CONTRAINDICATIONS:

Do not apply EURAX topically to patients who develop sensitivity, are allergic to it, or manifest a primary irritation response to topical medications.

WARNINGS:

Discontinue treatment with this product if severe irritation or sensitization develops, and institute appropriate therapy.

PRECAUTIONS:

Do not apply EURAX in the eyes or mouth because it may cause irritation. Do not apply on acutely inflamed skin or raw or weeping surfaces until the acute inflammation has subsided. It is not known whether EURAX can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. EURAX should be given to a pregnant woman only if clearly needed.

PRECAUTIONS:

Safety and effectiveness in pediatric patients have not been established. Clinical studies with EURAX did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects.

ADVERSE REACTIONS:

Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients. This preparation is not for ophthalmic, oral, or intravaginal use.
To report SUSPECTED ADVERSE REACTIONS, contact Journey Medical Corporation at 1-855-531-1859 or FDA at www.fda.gov/medwatch or call 1-800-FDA-1088. For topical use only. Please see Full Prescribing Information .

Important Safety Information for Accutane® (isotretinoin)

What is the most important information I should know about Accutane?

Accutane is used to treat a type of severe acne (nodular acne) that has not been helped by other treatments, including antibiotics.

Accutane can harm your unborn baby, including birth defects (deformed babies), loss of a baby before birth (miscarriage), death of the baby, and early (premature) births. Patients who are pregnant or who plan to become pregnant must not take Accutane.

Patient must not get pregnant:

  • for 1 month before starting Accutane
  • while taking Accutane
  • for 1 month after stopping Accutane

If you get pregnant while taking Accutane, stop taking it right away and call your healthcare provider.

Accutane is only for patients who can understand and agree to follow all the instructions in the iPLEDGE® REMS. Patients taking Accutane must register in the iPLEDGE® Pregnancy Registry at 1-866-495-0654 or www.ipledgeprogram.com. See your healthcare provider for further information.

Accutane can cause serious mental health problems, including:

  • depression.
  • psychosis. (seeing or hearing things that are not real)
  • suicide. Some patients taking Accutane have had thoughts about hurting themselves or suicide. Consult your healthcare provider if you have such thoughts.

Stop Accutane and call your doctor right away if you or a family member notices that you have any of the following signs and symptoms of depression or psychosis:

  • start to feel sad or have crying spells
  • lose interest in activities you once enjoyed
  • sleep too much or have trouble sleeping
  • become more irritable, angry, or aggressive than usual (for example, temper outbursts, thoughts of violence)
  • have a change in your appetite or body weight
  • have trouble concentrating
  • withdraw from your friends or family
  • feel like you have no energy
  • have feelings of worthlessness or guilt
  • start having thoughts about hurting yourself or taking your own life (suicidal thoughts)
  • start acting on dangerous impulses
  • start seeing or hearing things that are not real

After stopping Accutane, you may also need follow-up mental health care if you had any of these symptoms.

Who should not take Accutane?

  • Do not take Accutane if you are pregnant, plan to become pregnant, or become pregnant during Accutane treatment. Accutane causes life-threatening birth defects. See “What is the most important information I should know about Accutane?”
  • Do not take Accutane if you are allergic to anything in it. See the end of the Medication Guide for a complete list of ingredients in Accutane.

What should I tell my doctor before taking Accutane?

Tell your doctor if you or a family member has any of the following health conditions:

  • mental problems
  • asthma
  • liver disease
  • diabetes
  • heart disease
  • bone loss (osteoporosis) or weak bones
  • an eating problem called anorexia nervosa (where people eat too little)
  • food or medicine allergies

Tell your doctor if you are pregnant or breastfeeding. Accutane must not be used by women who are pregnant or breastfeeding.

Tell your doctor about all of the medicines you take including prescription and non-prescription medicines, vitamins and herbal supplements. Accutane and certain other medicines can interact with each other, sometimes causing serious side effects. Especially tell your doctor if you take:

  • Vitamin A supplements. Vitamin A in high doses has many of the same side effects as Accutane. Taking both together may increase your chance of getting side effects.
  • Tetracycline antibiotics. Tetracycline antibiotics taken with Accutane can increase the chances of getting increased pressure in the brain.
  • Progestin-only birth control pills (mini-pills). They may not work while you take Accutane. Ask your doctor or pharmacist if you are not sure what type you are using.
  • Dilantin (phenytoin). This medicine taken with Accutane may weaken your bones.
  • Corticosteroid medicines. These medicines taken with Accutane may weaken your bones.
  • St. John’s Wort. This herbal supplement may make birth control pills work less effectively.

These medicines should not be used with Accutane unless your doctor tells you it is okay.

Know the medicines you take. Keep a list of them to show to your doctor and pharmacist. Do not take any new medicine without talking with your doctor.

What should I avoid while taking Accutane?

  • Do not get pregnant while taking Accutane and for one month after stopping Accutane. See “What is the most important information I should know about Accutane?”
  • Do not breast feed while taking Accutane and for one month after stopping Accutane. We do not know if Accutane can pass through your milk and harm the baby.
  • Do not give blood while you take Accutane and for one month after stopping Accutane. If someone who is pregnant gets your donated blood, their baby may be exposed to Accutane and may be born with birth defects.
  • Do not take other medicines or herbal products with Accutane unless you talk to your doctor. See “What should I tell my doctor before taking Accutane?”
  • Do not drive at night until you know if Accutane has affected your vision. Accutane may decrease your ability to see in the dark.
  • Do not have cosmetic procedures to smooth your skin, including waxing, dermabrasion, or laser procedures, while you are using Accutane and for at least 6 months after you stop. Accutane can increase your chance of scarring from these procedures. Check with your doctor for advice about when you can have cosmetic procedures.
  • Avoid sunlight and ultraviolet lights as much as possible. Tanning machines use ultraviolet lights. Accutane may make your skin more sensitive to light.
  • Do not share Accutane with other people. It can cause birth defects and other serious health problems.

What are the possible side effects of Accutane?

  • Accutane can harm your unborn baby, including birth defects (deformed babies), loss of a baby before birth (miscarriage), death of the baby, and early (premature) births.
  • Accutane can cause serious mental health problems.
  • Serious brain problems. Accutane can increase the pressure in your brain. This can lead to permanent loss of eyesight and, in rare cases, death. Stop taking Accutane and call your healthcare provider right away if you get any of these signs of increased brain pressure:
    • bad headache
    • blurred vision
    • dizziness
    • nausea or vomiting
    • seizures (convulsions)
    • stroke
  • Skin problems. Skin rash can occur in patients taking Accutane. In some patients a rash can be serious. Stop using Accutane and call your healthcare provider immediately if you develop:
    • conjunctivitis (red or inflamed eyes, like “pink eye”)
    • rash with a fever
    • blisters on legs, arms or face and/or sores in your mouth, throat, nose, eyes
    • skin begins to peel
  • Stomach area (abdomen) problems. Certain symptoms may mean your internal organs are being damaged, such as the liver, pancreas, bowel (intestines), and esophagus (connection between mouth and stomach). If your organs are damaged, they may not get better even after you stop taking Accutane. Stop Accutane and call your healthcare provider if you get:
    • severe stomach, chest or bowel pain
    • trouble swallowing or painful swallowing
    • new or worsening heartburn
    • diarrhea
    • rectal bleeding
    • yellowing of your skin or eyes
    • dark urine
  • Bone or muscle problems. Accutane may affect your bones, muscles, and ligaments and cause pain in your joints and muscles. Tell your healthcare provider if you plan hard physical activity during treatment or get back or joint pain or broken bones. Stop Accutane and call your healthcare provider immediately if you have muscle weakness. Muscle weakness with or without pain can be a sign of serious muscle damage. Accutane may stop long bone growth in teenagers who are still growing.
  • Hearing problems. Stop using Accutane and call your healthcare provider if your hearing gets worse or if you have ringing in your ears. Your hearing loss may be permanent.
  • Vision problems. Accutane may affect your ability to see in the dark. Stop taking Accutane and call your healthcare provider right away if you have problems with your vision or dryness of the eyes that is painful or constant. If you wear contact lenses, you may have trouble wearing them during and after you stop treatment with Accutane.
  • Lipid (fats and cholesterol in blood) problems. Accutane can raise the level of fats and cholesterol in your blood. This can be a serious problem. Return to your doctor for blood tests to check your lipids and to get any needed treatment. These problems usually go away when Accutane treatment is finished.
  • Serious allergic reactions. Stop taking Accutane and get emergency care right away if you develop hives, a swollen face or mouth, or have trouble breathing. Stop taking Accutane and call your healthcare provider if you get a fever, rash, or red patches or bruises on your legs.
  • Blood sugar problems. Accutane may cause blood sugar problems including diabetes. Tell your healthcare professional if you are very thirsty or urinate a lot.
  • Decreased red or white blood cells. Call your healthcare professional if you have trouble breathing, faint, or feel weak.

The common, less serious side effects of Accutane include:

  • Dry skin
  • Chapped lips
  • Dry eyes
  • Dry nose that may lead to nosebleeds

These are not all of the possible side effects of Accutane. Call your healthcare professional for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or JG Pharma, Inc. at 1-844-325-3350.

Click here to see the full Prescribing Information for Boxed Warning, Contraindications, other Important Warnings and Precautions, Drug Interactions, Use in Specific Populations, and other Adverse Reactions.

 

Important Safety Information

  • Do not use AMZEEQ if you are allergic to AMZEEQ or any tetracycline medicine. Stop using AMZEEQ right away and call your doctor if you get a rash or other allergic symptom.
  • Before using AMZEEQ, tell your doctor about all of your medical conditions and the medicines you take. Do not use AMZEEQ if you are pregnant, may become pregnant or are nursing. If you become pregnant while using AMZEEQ, talk to your doctor. Tetracycline medicine when taken by mouth during pregnancy, infancy and/or childhood up to the age of 8 years may permanently discolor teeth (yellow-gray-brown) and may slow the growth of bones.
  • AMZEEQ is flammable. Avoid fire, flame, and smoking when applying and right after you apply AMZEEQ.
  • Protect your skin from the sun while using AMZEEQ. Avoid sunlight or artificial sunlight such as sunlamps or tanning beds. Stop using AMZEEQ if you get a sunburn.
  • When taken by mouth, minocycline may cause feelings of lightheadedness, dizziness or spinning. You should not drive or operate dangerous machinery if you have these symptoms.

AMZEEQ is a topical foam that contains minocycline, a tetracycline medicine. It is not taken by mouth. However, tetracyclines, when taken by mouth (capsules or tablets), may cause serious side effects, including: diarrhea which may be caused by an infection and can cause watery or bloody stools; loss of appetite; tiredness; yellowing of your skin or eyes (jaundice); bleeding more easily than normal; confusion; sleepiness; vision changes, including blurred vision, double vision, or permanent vision loss; unusual headaches; fever; rash; joint pain; body weakness; discoloration or darkening of your skin, scars, teeth, or gums. Call your doctor right away if these side effects occur.

The most common side effect of AMZEEQ is headache.

These are not all of the possible side effects with AMZEEQ. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication

AMZEEQ® (minocycline) topical foam, 4% is a prescription medicine used on the skin (topical) for the treatment of pimples and red bumps (non-nodular inflammatory lesions) of moderate to severe acne in patients 9 years of age and older.

AMZEEQ should not be used for the treatment of infections. It is not known if AMZEEQ is safe and effective in children under 9 years of age. AMZEEQ is for use on skin only (topical use). AMZEEQ is not for use in your mouth, eyes or vagina.

Please see full Prescribing Information and Patient Information.

IMPORTANT SAFETY INFORMATION

  • Do not use ZILXI if you are allergic to ZILXI or any tetracycline medicine. Stop using ZILXI right away and call your doctor if you get a rash or other allergic symptom.
  • Before using ZILXI, tell your doctor about all of your medical conditions and the medicines you take. Do not use ZILXI if you are pregnant, may become pregnant or are nursing. If you become pregnant while using ZILXI, talk to your doctor. Tetracycline medicine when taken by mouth during pregnancy, infancy and/or childhood up to the age of 8 years may permanently discolor teeth (yellow-gray-brown) and may slow the growth of bones.
  • ZILXI is flammable. Avoid fire, flames, and smoking when applying and right after you apply ZILXI.
  • Protect your skin from the sun while using ZILXI. Avoid sunlight or artificial sunlight such as sunlamps or tanning beds. Stop using ZILXI if you get a sunburn.
  • When taken by mouth, minocycline may cause feelings of lightheadedness, dizziness or spinning. You should not drive or operate dangerous machinery if you have these symptoms.

ZILXI is a topical foam that contains minocycline, a tetracycline medicine. It is not taken by mouth. However, tetracyclines, when taken by mouth (capsules or tablets), may cause serious side effects, including: diarrhea which may be caused by an infection and can cause watery or bloody stools; loss of appetite; tiredness; yellowing of your skin or eyes (jaundice); bleeding more easily than normal; confusion; sleepiness; vision changes, including blurred vision, double vision, or permanent vision loss; unusual headaches; fever; rash; joint pain; body weakness; discoloration or darkening of your skin, scars, teeth, or gums. Call your doctor right away if these side effects occur.

The most common side effect of ZILXI is diarrhea.

These are not all of the possible side effects with ZILXI. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Patient Information.

INDICATION

ZILXI® (minocycline) topical foam, 1.5% is a prescription medicine used on the skin (topical) to treat adults with pimples and bumps caused by a condition called rosacea.

ZILXI should not be used for the treatment of infections. It is not known if ZILXI is safe and effective in children. ZILXI is for use on the skin only (topical use). ZILXI is not for use in your mouth, eyes or vagina.

 

Important Safety Information

INDICATIONS AND USAGE

Luxamend® is indicated for use in:

  • Full thickness wounds
  • Pressure sores
  • Dermal ulcers, including lower leg ulcers
  • Superficial wounds
  • First- and second-degree burns, including sunburns
  • Dermal donor and graft site management
  • Radiation dermatitis
  • Minor abrasions
CONTRAINDICATIONS

Luxamend is contraindicated for use:

  • On bleeding wounds
  • On skin rashes related to food or medicine allergies
  • In patients with known allergy to any of its ingredients
WARNINGS
  • In radiation therapy, apply only as directed by the treating physician
  • Do not apply within 4 hours prior to a radiation session
  • Do not apply to dermal grafts until the graft has successfully taken
  • Keep out of reach of children
PRECAUTIONS
  • Consult a physician before treating any dermal wound
  • Use only as directed
  • Luxamend does not contain sunscreen and should not be used before extended sun exposure
  • Not recommended for allergic skin rashes due to limited data
  • If signs of infection are present, appropriate treatment should be started
  • Luxamend may be continued during anti-infective therapy if clinically indicated
  • If condition does not improve within 10 to 14 days, consult a physician
SIDE EFFECTS

Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of medical products to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for Full Prescribing Information.

IMPORTANT SAFETY INFORMATION

INDICATIONS AND USAGE: EXELDERM® (sulconazole nitrate) Cream and Solution, 1.0% are antifungal agents indicated for the treatment of tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis,* and for the treatment of tinea versicolor. *Efficacy for this organism in the organ system was studied in fewer than 10 infections. EXELDERM® Cream is also indicated for the treatment of tinea pedis (athlete’s foot). Effectiveness of EXELDERM® Solution has not been proven in tinea pedis.

SUMMARY OF RISK INFORMATION FOR EXELDERM® CREAM AND SOLUTION

CONTRAINDICATIONS: EXELDERM® (sulconazole nitrate) Cream and Solution, 1.0% are contraindicated in patients who have a history of hypersensitivity to any of its ingredients.

PRECAUTIONS: Use EXELDERM® (sulconazole nitrate) Cream and Solution, as directed by your physician only. EXELDERM® (sulconazole nitrate) Cream and Solution, 1.0% are for external use only. Avoid contact with the eyes. If irritation develops, the cream or solution should be discontinued and appropriate therapy instituted.

There are no adequate and well-controlled studies in pregnant women. Sulconazole nitrate should be used during pregnancy only if clearly needed. Sulconazole nitrate has been shown to be embryotoxic in rats when given in doses of 125 times the adult human dose (in mg/kg). The drug was not teratogenic in rats or rabbits at oral doses of 50 mg/kg/day. Sulconazole nitrate given orally to rats at a dose 125 times the human dose resulted in prolonged gestation and dystocia. Several females died during the prenatal period, most likely due to labor complications.

It is not known whether sulconazole nitrate is excreted in human milk. Caution should be exercised when sulconazole nitrate is administered to a nursing woman.

Safety and effectiveness in children have not been established.

ADVERSE REACTIONS: There were no systemic effects and only infrequent cutaneous adverse reactions in 1185 patients treated with sulconazole nitrate cream in controlled clinical trials. Approximately 3% of these patients reported itching, 3% burning or stinging, and 1% redness. These complaints did not usually interfere with treatment.

There were no systemic effects and only infrequent cutaneous adverse reactions in 370 patients treated with sulconazole nitrate solution in controlled clinical trials. Approximately 1% of these patients reported itching and 1% burning or stinging. These complaints did not usually interfere with treatment.

These preparations are not for ophthalmic, oral, or intravaginal use.

For topical use only. Please see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

IMPORTANT SAFETY INFORMATION

INDICATIONS AND USAGE: EXELDERM® (sulconazole nitrate) Cream and Solution, 1.0% are antifungal agents indicated for the treatment of tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis,* and for the treatment of tinea versicolor.

*Efficacy for this organism in the organ system was studied in fewer than 10 infections. EXELDERM® Cream is also indicated for the treatment of tinea pedis (athlete’s foot). Effectiveness of EXELDERM® Solution has not been proven in tinea pedis.

SUMMARY OF RISK INFORMATION FOR EXELDERM® CREAM AND SOLUTION

CONTRAINDICATIONS: EXELDERM® (sulconazole nitrate) Cream and Solution, 1.0% are contraindicated in patients who have a history of hypersensitivity to any of its ingredients.

PRECAUTIONS: Use EXELDERM® (sulconazole nitrate) Cream and Solution as directed by your physician only. These products are for external use only. Avoid contact with the eyes. If irritation develops, discontinue use and initiate appropriate therapy.

There are no adequate and well-controlled studies in pregnant women. Sulconazole nitrate should be used during pregnancy only if clearly needed. Sulconazole nitrate has been shown to be embryotoxic in rats at high doses. The drug was not teratogenic in rats or rabbits at oral doses of 50 mg/kg/day. High-dose exposure resulted in prolonged gestation and labor complications.

It is not known whether sulconazole nitrate is excreted in human milk. Caution should be exercised when administered to a nursing woman.

Safety and effectiveness in children have not been established.

ADVERSE REACTIONS: There were no systemic effects and only infrequent cutaneous adverse reactions in 1185 patients treated with sulconazole nitrate cream. Approximately 3% reported itching, 3% burning or stinging, and 1% redness. These complaints did not usually interfere with treatment.

There were no systemic effects and only infrequent cutaneous adverse reactions in 370 patients treated with sulconazole nitrate solution. Approximately 1% reported itching and 1% burning or stinging. These complaints did not usually interfere with treatment.

These preparations are not for ophthalmic, oral, or intravaginal use.

For topical use only. Please see Full Prescribing Information .

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088 .

Important Safety Information

Indications and Usage

TARGADOX® (doxycycline hyclate tablets) is a tetracycline-class antimicrobial indicated as adjunctive therapy for severe acne. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of TARGADOX and other antibacterial drugs, TARGADOX should be used only as indicated. The usual dose of oral doxycycline is 200mg on the first day of treatment (administered 100mg every 12 hours), followed by a maintenance dose of 100mg daily. There are no adequate and well-controlled studies on the use of doxycycline in pregnant women.

Contraindications

This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Important Safety Information

  • TARGADOX tablets are contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.
  • The use of tetracycline class drugs during tooth development (last half of pregnancy, infancy, and childhood to 8 years) may cause permanent discoloration of the teeth and should not be used in this group (except for anthrax).
  • Clostridium difficile-associated diarrhea (CDAD) has been reported with nearly all antibacterial agents, including doxycycline, and may range from mild diarrhea to fatal colitis.
  • Photosensitivity can occur with tetracycline-class drugs.
  • TARGADOX patients should minimize or avoid excessive exposure to natural or artificial sunlight and consider using sunscreen or sunblock.
    Advise patients to discontinue therapy at the first evidence of skin erythema.
  • Intracranial Hypertension (IH) has been associated with the use of tetracyclines.
  • Concurrent use of tetracycline may render oral contraceptives less effective.
  • Absorption of tetracyclines is impaired by antacids containing aluminum, calcium, or magnesium, bismuth subsalicylate, and iron-containing preparations.
  • Esophagitis has been associated with the use of tetracyclines so patients should be advised to drink fluids liberally along with doxycycline.
  • Adverse reactions observed in patients receiving tetracyclines include anorexia, nausea, vomiting, diarrhea, rash, photosensitivity, urticaria, hemolytic anemia, toxic epidermal necrolysis, Stevens-Johnson syndrome, increased blood urea nitrogen (BUN) and hypersensitivity reactions.

You are encouraged to report negative side effects of prescription drugs to Journey Medical Corp. at 1-855-531-1859 or the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for Full Prescribing Information.